Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: A prospective randomized clinical trial

Archives of Surgery

Volumn 144, Issue 10, 2009, Pages 933-937

  Okabayashi, Takehiro ^a   Nishimori, Isao ^a   Yamashita, Koichi ^a   Sugimoto, Takeki ^a   Maeda, Hiromichi ^a   Yatabe, Tomoaki ^a   Kohsaki, Takuhiro ^a   Kobayashi, Michiya ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; MALE; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PANCREATICOSPLENECTOMY; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SURGICAL STRESS; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; CARCINOMA; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70350217488     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2009.176     Document Type: Article

References (21)

1. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004; 126(3):879-887. (Pubitemid 39258045)
2. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-124.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-778. (Pubitemid 30128815)
4. Huo TI, Lui WY, Huang YH, et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol. 2003;98(10):2293-2298. (Pubitemid 37305373)
5. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002;6(1): 88-94. (Pubitemid 40433594)
6. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-366. (Pubitemid 36232926)
7. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367. (Pubitemid 34940724)
8. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461. (Pubitemid 43200296)
9. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041-2047. (Pubitemid 37430587)
10. Toft P, Jorgensen HS, Toennesen E, Christiansen C. Intensive insulin therapy to non-cardiac ICU patients: a prospective study. Eur J Anaesthesiol. 2006;23 (8):705-709.
11. Dronge AS, Perkal MF, Kancir S, Concato J, Aslm M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006; 141(4):375-380.
12. Brunicardi FC, Andersen DK, Billiar TR, Dunn DL. Part II: pancreas. In: Hunter JG, Pollock RE, eds. Schwartz's Principles of Surgery. 8th ed. New York, NY: McGraw-Hill Co Inc; 2004:1221-1296.
13. Kono T, Hanazaki K, Yazawa K, et al. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs. 2005;29(1):83-87. (Pubitemid 41602009)
14. Alfonso A, Koops MK, Mong DP, Vigersky RA. Glycemic control with regular versus lispro insulin sliding scales in hospitalized type 2 diabetics. J Diabetes Complications. 2006;20(3):153-157.
15. Dickerson LM, Ye X, Sack JL, Hueston WJ. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized control trial. Ann Fam Med. 2003;1(1):29-35.
16. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106(1):160-163.
17. Hanazaki K, Nose Y, Brunicardi FC. Artificial endocrine pancreas. J Am Coll Surg. 2001;193(3):310-322.
18. Okabayashi T, Hnazaki K, Nishimori I, et al. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci. 2008;53(5):1405-1410.
19. Van den Berghe G. Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia. 2008; 51(6):911-915.
20. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139.
21. Jethwa P, Sodergren M, Lala A, et al. Diabetic control after total pancreatectomy. Dig Liver Dis. 2006;38(6):415-419.